Frequencies for first 10,000 rows of indi_pt variable in indi2011q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 2 0.02 0.02 ABDOMINAL DISTENSION | 1 0.01 0.03 ABDOMINAL INFECTION | 2 0.02 0.05 ABDOMINAL PAIN | 11 0.11 0.16 ABDOMINAL PAIN UPPER | 5 0.05 0.21 ABNORMAL BEHAVIOUR | 2 0.02 0.23 ABNORMAL FAECES | 1 0.01 0.24 ACCIDENTAL EXPOSURE | 1 0.01 0.25 ACNE | 153 1.53 1.78 ACROMEGALY | 2 0.02 1.80 ACUTE GRAFT VERSUS HOST DISEASE IN IN.. | 1 0.01 1.81 ACUTE LYMPHOCYTIC LEUKAEMIA | 49 0.49 2.30 ACUTE MYELOID LEUKAEMIA | 9 0.09 2.39 ACUTE MYELOID LEUKAEMIA RECURRENT | 3 0.03 2.42 ACUTE MYOCARDIAL INFARCTION | 5 0.05 2.47 ACUTE PROMYELOCYTIC LEUKAEMIA | 1 0.01 2.48 ACUTE SINUSITIS | 3 0.03 2.51 ADENOCARCINOMA | 2 0.02 2.53 ADENOMA BENIGN | 1 0.01 2.54 ADENOMYOSIS | 1 0.01 2.55 ADENOSQUAMOUS CELL LUNG CANCER | 3 0.03 2.58 ADRENAL DISORDER | 2 0.02 2.60 ADRENOCORTICAL CARCINOMA | 1 0.01 2.61 ADVERSE DRUG REACTION | 1 0.01 2.62 AFFECTIVE DISORDER | 8 0.08 2.70 AGE-RELATED MACULAR DEGENERATION | 3 0.03 2.73 AGITATION | 3 0.03 2.76 ALCOHOLISM | 2 0.02 2.78 ALLERGY PROPHYLAXIS | 2 0.02 2.80 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 13 0.13 2.93 ALOPECIA | 1 0.01 2.94 ANAEMIA | 20 0.20 3.14 ANAESTHETIC PREMEDICATION | 1 0.01 3.15 ANAL ABSCESS | 1 0.01 3.16 ANAL CANCER | 6 0.06 3.22 ANALGESIC THERAPY | 14 0.14 3.36 ANAPHYLACTIC REACTION | 1 0.01 3.37 ANAPHYLAXIS PROPHYLAXIS | 1 0.01 3.38 ANDROGENETIC ALOPECIA | 1 0.01 3.39 ANGER | 1 0.01 3.40 ANGINA PECTORIS | 11 0.11 3.51 ANGIOGRAM | 37 0.37 3.88 ANGIOPLASTY | 2 0.02 3.90 ANKYLOSING SPONDYLITIS | 22 0.22 4.12 ANTACID THERAPY | 3 0.03 4.15 ANTIALLERGIC THERAPY | 1 0.01 4.16 ANTIBIOTIC PROPHYLAXIS | 7 0.07 4.23 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS T.. | 1 0.01 4.24 ANTIBIOTIC THERAPY | 6 0.06 4.30 ANTICOAGULANT THERAPY | 19 0.19 4.49 ANTIEMETIC SUPPORTIVE CARE | 8 0.08 4.57 ANTIFUNGAL PROPHYLAXIS | 8 0.08 4.65 ANTIINFLAMMATORY THERAPY | 3 0.03 4.68 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 4.69 ANTIPLATELET THERAPY | 1 0.01 4.70 ANTIPYRESIS | 1 0.01 4.71 ANTIVIRAL PROPHYLAXIS | 5 0.05 4.76 ANXIETY | 68 0.68 5.44 ANXIETY DISORDER | 12 0.12 5.56 ANXIOLYTIC THERAPY | 1 0.01 5.57 AORTIC ANEURYSM REPAIR | 4 0.04 5.61 AORTIC BYPASS | 2 0.02 5.63 AORTIC DISSECTION | 1 0.01 5.64 AORTIC SURGERY | 2 0.02 5.66 AORTIC VALVE REPAIR | 3 0.03 5.69 AORTIC VALVE REPLACEMENT | 11 0.11 5.80 APLASIA PURE RED CELL | 1 0.01 5.81 APLASTIC ANAEMIA | 11 0.11 5.92 ARRHYTHMIA | 12 0.12 6.04 ARTERIAL DISORDER | 1 0.01 6.05 ARTERIOGRAM CORONARY | 3 0.03 6.08 ARTHRALGIA | 25 0.25 6.33 ARTHRITIS | 18 0.18 6.51 ARTHROPATHY | 2 0.02 6.53 ASCITES | 3 0.03 6.56 ASPERGILLOSIS | 2 0.02 6.58 ASTHMA | 80 0.80 7.38 ASTROCYTOMA, LOW GRADE | 6 0.06 7.44 ATHEROSCLEROSIS PROPHYLAXIS | 1 0.01 7.45 ATRIAL FIBRILLATION | 134 1.34 8.79 ATRIAL FLUTTER | 1 0.01 8.80 ATRIAL TACHYCARDIA | 2 0.02 8.82 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 24 0.24 9.06 AUTOIMMUNE THYROIDITIS | 1 0.01 9.07 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 3 0.03 9.10 AUTONOMIC NEUROPATHY | 2 0.02 9.12 B-CELL LYMPHOMA | 4 0.04 9.16 BACK DISORDER | 2 0.02 9.18 BACK PAIN | 28 0.28 9.46 BACTERIAL DISEASE CARRIER | 4 0.04 9.50 BARRETT'S OESOPHAGUS | 3 0.03 9.53 BASEDOW'S DISEASE | 1 0.01 9.54 BENIGN PROSTATIC HYPERPLASIA | 14 0.14 9.68 BILE DUCT CANCER | 5 0.05 9.73 BIPOLAR DISORDER | 31 0.31 10.04 BIPOLAR I DISORDER | 2 0.02 10.06 BLADDER CANCER | 3 0.03 10.09 BLADDER DISORDER | 2 0.02 10.11 BLADDER DYSFUNCTION | 1 0.01 10.12 BLADDER SPASM | 1 0.01 10.13 BLOOD CALCIUM | 1 0.01 10.14 BLOOD CHOLESTEROL | 11 0.11 10.25 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 10.27 BLOOD CHOLESTEROL INCREASED | 62 0.62 10.89 BLOOD DISORDER | 1 0.01 10.90 BLOOD GLUCOSE ABNORMAL | 2 0.02 10.92 BLOOD GLUCOSE DECREASED | 1 0.01 10.93 BLOOD GROWTH HORMONE ABNORMAL | 1 0.01 10.94 BLOOD HOMOCYSTEINE INCREASED | 1 0.01 10.95 BLOOD MAGNESIUM DECREASED | 1 0.01 10.96 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 10.97 BLOOD PHOSPHORUS DECREASED | 1 0.01 10.98 BLOOD POTASSIUM DECREASED | 1 0.01 10.99 BLOOD PRESSURE | 22 0.22 11.21 BLOOD PRESSURE ABNORMAL | 12 0.12 11.33 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 11.34 BLOOD PRESSURE INCREASED | 4 0.04 11.38 BLOOD PRESSURE MANAGEMENT | 1 0.01 11.39 BLOOD PRESSURE SYSTOLIC INCREASED | 2 0.02 11.41 BLOOD PROLACTIN INCREASED | 1 0.01 11.42 BLOOD TESTOSTERONE DECREASED | 2 0.02 11.44 BLOOD TESTOSTERONE INCREASED | 1 0.01 11.45 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 11.46 BLOOD TRIGLYCERIDES INCREASED | 2 0.02 11.48 BLOOD URIC ACID INCREASED | 1 0.01 11.49 BONE DENSITY ABNORMAL | 1 0.01 11.50 BONE DENSITY INCREASED | 1 0.01 11.51 BONE DISORDER | 6 0.06 11.57 BONE LESION | 4 0.04 11.61 BONE MARROW CONDITIONING REGIMEN | 22 0.22 11.83 BONE MARROW TRANSPLANT | 1 0.01 11.84 BONE NEOPLASM MALIGNANT | 1 0.01 11.85 BONE PAIN | 8 0.08 11.93 BONE SARCOMA | 2 0.02 11.95 BRAIN ABSCESS | 1 0.01 11.96 BRAIN CONTUSION | 2 0.02 11.98 BRAIN INJURY | 3 0.03 12.01 BRAIN STEM GLIOMA | 1 0.01 12.02 BRAIN STEM SYNDROME | 1 0.01 12.03 BREAKTHROUGH PAIN | 6 0.06 12.09 BREAST CANCER | 127 1.27 13.36 BREAST CANCER FEMALE | 2 0.02 13.38 BREAST CANCER METASTATIC | 16 0.16 13.54 BREAST CANCER STAGE I | 1 0.01 13.55 BRONCHIAL CARCINOMA | 1 0.01 13.56 BRONCHIAL HYPERREACTIVITY | 2 0.02 13.58 BRONCHIECTASIS | 1 0.01 13.59 BRONCHITIS | 8 0.08 13.67 BRONCHITIS CHRONIC | 4 0.04 13.71 BURKITT'S LYMPHOMA | 5 0.05 13.76 CANCER PAIN | 18 0.18 13.94 CANDIDIASIS | 2 0.02 13.96 CARCINOID SYNDROME | 1 0.01 13.97 CARCINOID TUMOUR | 4 0.04 14.01 CARCINOID TUMOUR PULMONARY | 2 0.02 14.03 CARDIAC ASSISTANCE DEVICE USER | 1 0.01 14.04 CARDIAC DISORDER | 20 0.20 14.24 CARDIAC FAILURE | 9 0.09 14.33 CARDIAC FAILURE CHRONIC | 1 0.01 14.34 CARDIAC FAILURE CONGESTIVE | 8 0.08 14.42 CARDIAC NEOPLASM UNSPECIFIED | 1 0.01 14.43 CARDIAC OPERATION | 5 0.05 14.48 CARDIAC PACEMAKER INSERTION | 1 0.01 14.49 CARDIAC VALVE PROSTHESIS USER | 2 0.02 14.51 CARDIAC VENTRICULOGRAM LEFT | 2 0.02 14.53 CARDIOGENIC SHOCK | 2 0.02 14.55 CARDIOPULMONARY BYPASS | 2 0.02 14.57 CARDIOVASCULAR DISORDER | 3 0.03 14.60 CARDIOVASCULAR EVENT PROPHYLAXIS | 6 0.06 14.66 CARDIOVASCULAR INSUFFICIENCY | 2 0.02 14.68 CARDIOVERSION | 1 0.01 14.69 CARTILAGE INJURY | 1 0.01 14.70 CASTLEMAN'S DISEASE | 1 0.01 14.71 CATARACT | 2 0.02 14.73 CATHETER PLACEMENT | 1 0.01 14.74 CATHETERISATION CARDIAC | 13 0.13 14.87 CELLULITIS | 2 0.02 14.89 CEREBRAL INFARCTION | 4 0.04 14.93 CEREBRAL PALSY | 1 0.01 14.94 CEREBROVASCULAR ACCIDENT | 5 0.05 14.99 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 3 0.03 15.02 CEREBROVASCULAR SPASM | 1 0.01 15.03 CHEMOTHERAPY | 24 0.24 15.27 CHEST PAIN | 8 0.08 15.35 CHOLECYSTITIS | 1 0.01 15.36 CHONDROBLASTOMA | 1 0.01 15.37 CHRONIC INFANTILE NEUROLOGICAL CUTANE.. | 1 0.01 15.38 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 15.39 CHRONIC LYMPHOCYTIC LEUKAEMIA | 16 0.16 15.55 CHRONIC MYELOID LEUKAEMIA | 52 0.52 16.07 CHRONIC MYELOID LEUKAEMIA TRANSFORMAT.. | 1 0.01 16.08 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 82 0.82 16.90 CHRONIC SINUSITIS | 1 0.01 16.91 CHYLOTHORAX | 1 0.01 16.92 CIRCADIAN RHYTHM SLEEP DISORDER | 1 0.01 16.93 CITROBACTER INFECTION | 2 0.02 16.95 CLUSTER HEADACHE | 1 0.01 16.96 COGNITIVE DISORDER | 1 0.01 16.97 COLITIS | 6 0.06 17.03 COLITIS ULCERATIVE | 18 0.18 17.21 COLON CANCER | 11 0.11 17.32 COLON CANCER METASTATIC | 5 0.05 17.37 COLORECTAL CANCER | 30 0.30 17.67 COLORECTAL CANCER METASTATIC | 1 0.01 17.68 COMPLEX PARTIAL SEIZURES | 4 0.04 17.72 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 17.73 COMPUTERISED TOMOGRAM | 6 0.06 17.79 COMPUTERISED TOMOGRAM ABDOMEN | 1 0.01 17.80 COMPUTERISED TOMOGRAM HEAD | 1 0.01 17.81 CONGENITAL APLASTIC ANAEMIA | 1 0.01 17.82 CONGENITAL CYSTIC KIDNEY DISEASE | 1 0.01 17.83 CONJUNCTIVITIS | 4 0.04 17.87 CONSTIPATION | 36 0.36 18.23 CONSTIPATION PROPHYLAXIS | 1 0.01 18.24 CONTRACEPTION | 339 3.39 21.63 CONTUSION | 1 0.01 21.64 CONVULSION | 22 0.22 21.86 CONVULSION PROPHYLAXIS | 3 0.03 21.89 CORNEAL OPACITY | 1 0.01 21.90 CORONARY ANGIOPLASTY | 1 0.01 21.91 CORONARY ARTERIAL STENT INSERTION | 9 0.09 22.00 CORONARY ARTERY BYPASS | 40 0.40 22.40 CORONARY ARTERY DISEASE | 14 0.14 22.54 CORONARY ARTERY INSUFFICIENCY | 1 0.01 22.55 CORONARY ENDARTERECTOMY | 1 0.01 22.56 COUGH | 9 0.09 22.65 COX-MAZE PROCEDURE | 3 0.03 22.68 CROHN'S DISEASE | 89 0.89 23.57 CUSHING'S SYNDROME | 1 0.01 23.58 CYST | 2 0.02 23.60 CYSTIC FIBROSIS | 2 0.02 23.62 CYSTITIS | 1 0.01 23.63 CYSTITIS INTERSTITIAL | 2 0.02 23.65 CYTOMEGALOVIRUS INFECTION | 3 0.03 23.68 CYTOMEGALOVIRUS TEST POSITIVE | 2 0.02 23.70 DECREASED APPETITE | 1 0.01 23.71 DEEP VEIN THROMBOSIS | 5 0.05 23.76 DELIRIUM | 3 0.03 23.79 DELUSION | 3 0.03 23.82 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 2 0.02 23.84 DEMENTIA | 4 0.04 23.88 DEMENTIA ALZHEIMER'S TYPE | 11 0.11 23.99 DENTAL CARE | 1 0.01 24.00 DENTAL OPERATION | 1 0.01 24.01 DEPENDENCE | 1 0.01 24.02 DEPRESSED MOOD | 3 0.03 24.05 DEPRESSION | 164 1.64 25.69 DEPRESSIVE SYMPTOM | 4 0.04 25.73 DERMATITIS ACNEIFORM | 3 0.03 25.76 DERMATITIS ATOPIC | 4 0.04 25.80 DERMATOMYOSITIS | 1 0.01 25.81 DETOXIFICATION | 3 0.03 25.84 DEVICE RELATED INFECTION | 5 0.05 25.89 DEVICE THERAPY | 1 0.01 25.90 DIABETES MELLITUS | 196 1.96 27.86 DIABETIC NEUROPATHY | 1 0.01 27.87 DIABETIC RETINAL OEDEMA | 1 0.01 27.88 DIARRHOEA | 15 0.15 28.03 DIFFUSE LARGE B-CELL LYMPHOMA | 22 0.22 28.25 DIURETIC THERAPY | 2 0.02 28.27 DIVERTICULITIS | 1 0.01 28.28 DIZZINESS | 2 0.02 28.30 DRUG ABUSE | 2 0.02 28.32 DRUG DEPENDENCE | 4 0.04 28.36 DRUG DETOXIFICATION | 1 0.01 28.37 DRUG EFFECT DECREASED | 1 0.01 28.38 DRUG THERAPY | 2 0.02 28.40 DRUG TOXICITY PROPHYLAXIS | 1 0.01 28.41 DRUG WITHDRAWAL SYNDROME | 1 0.01 28.42 DRY EYE | 5 0.05 28.47 DRY SKIN | 1 0.01 28.48 DUODENAL ULCER | 1 0.01 28.49 DYSCHEZIA | 8 0.08 28.57 DYSFUNCTIONAL UTERINE BLEEDING | 4 0.04 28.61 DYSKINESIA | 1 0.01 28.62 DYSLIPIDAEMIA | 9 0.09 28.71 DYSMENORRHOEA | 16 0.16 28.87 DYSPEPSIA | 10 0.10 28.97 DYSPHAGIA | 1 0.01 28.98 DYSPNOEA | 3 0.03 29.01 DYSTHYMIC DISORDER | 2 0.02 29.03 DYSURIA | 3 0.03 29.06 EATING DISORDER | 2 0.02 29.08 ECHOCARDIOGRAM | 2 0.02 29.10 ECZEMA | 3 0.03 29.13 ELECTROLYTE SUBSTITUTION THERAPY | 1 0.01 29.14 EMBOLISM VENOUS | 1 0.01 29.15 EMPHYSEMA | 6 0.06 29.21 ENDARTERECTOMY | 1 0.01 29.22 ENDOMETRIAL CANCER STAGE IV | 2 0.02 29.24 ENDOMETRIAL HYPERTROPHY | 1 0.01 29.25 ENDOMETRIOSIS | 4 0.04 29.29 ENERGY INCREASED | 1 0.01 29.30 ENTERAL NUTRITION | 1 0.01 29.31 ENTEROCOCCAL SEPSIS | 2 0.02 29.33 ENTEROCOLITIS | 2 0.02 29.35 EPIDIDYMITIS | 1 0.01 29.36 EPIDURAL ANAESTHESIA | 1 0.01 29.37 EPIDURITIS | 1 0.01 29.38 EPILEPSY | 49 0.49 29.87 ERECTILE DYSFUNCTION | 16 0.16 30.03 ERYTHEMA | 1 0.01 30.04 ESSENTIAL HYPERTENSION | 6 0.06 30.10 EVANS SYNDROME | 1 0.01 30.11 EXTRADURAL ABSCESS | 1 0.01 30.12 EXTRAPYRAMIDAL DISORDER | 3 0.03 30.15 EYE ALLERGY | 1 0.01 30.16 EYE IRRITATION | 1 0.01 30.17 EYE OPERATION | 1 0.01 30.18 EYE PAIN | 1 0.01 30.19 EYE PRURITUS | 1 0.01 30.20 FABRY'S DISEASE | 2 0.02 30.22 FACIAL NEURALGIA | 2 0.02 30.24 FACIAL SPASM | 1 0.01 30.25 FACTOR VIII DEFICIENCY | 1 0.01 30.26 FAILURE TO THRIVE | 1 0.01 30.27 FATIGUE | 6 0.06 30.33 FEBRILE NEUTROPENIA | 4 0.04 30.37 FEELING OF RELAXATION | 1 0.01 30.38 FEMUR FRACTURE | 2 0.02 30.40 FIBROMA | 1 0.01 30.41 FIBROMYALGIA | 19 0.19 30.60 FISTULA REPAIR | 1 0.01 30.61 FISTULOGRAM | 2 0.02 30.63 FLUID REPLACEMENT | 1 0.01 30.64 FLUID RETENTION | 13 0.13 30.77 FLUSHING | 1 0.01 30.78 FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 1 0.01 30.79 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR .. | 4 0.04 30.83 FRACTURE | 9 0.09 30.92 FREQUENT BOWEL MOVEMENTS | 1 0.01 30.93 FRONTOTEMPORAL DEMENTIA | 1 0.01 30.94 FUNGAL INFECTION | 2 0.02 30.96 GAIT DISTURBANCE | 1 0.01 30.97 GALLBLADDER DISORDER | 1 0.01 30.98 GALLBLADDER PAIN | 1 0.01 30.99 GANGRENE | 2 0.02 31.01 GASTRIC CANCER | 19 0.19 31.20 GASTRIC DISORDER | 9 0.09 31.29 GASTRIC ULCER | 5 0.05 31.34 GASTRIC ULCER HAEMORRHAGE | 1 0.01 31.35 GASTRITIS | 18 0.18 31.53 GASTRITIS EROSIVE | 4 0.04 31.57 GASTRITIS PROPHYLAXIS | 8 0.08 31.65 GASTROENTERITIS | 2 0.02 31.67 GASTROINTESTINAL CARCINOMA | 1 0.01 31.68 GASTROINTESTINAL DISORDER | 3 0.03 31.71 GASTROINTESTINAL DISORDER THERAPY | 2 0.02 31.73 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 31.74 GASTROINTESTINAL STROMAL TUMOUR | 7 0.07 31.81 GASTROOESOPHAGEAL CANCER | 7 0.07 31.88 GASTROOESOPHAGEAL REFLUX DISEASE | 66 0.66 32.54 GASTROOESOPHAGEAL REFLUX PROPHYLAXIS | 1 0.01 32.55 GAUCHER'S DISEASE | 2 0.02 32.57 GENERAL ANAESTHESIA | 3 0.03 32.60 GENERALISED ANXIETY DISORDER | 2 0.02 32.62 GENITAL HERPES | 4 0.04 32.66 GESTATIONAL DIABETES | 1 0.01 32.67 GLAUCOMA | 14 0.14 32.81 GLIOBLASTOMA | 9 0.09 32.90 GLIOBLASTOMA MULTIFORME | 3 0.03 32.93 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 32.94 GOITRE | 1 0.01 32.95 GOUT | 13 0.13 33.08 GRAFT VERSUS HOST DISEASE | 7 0.07 33.15 GRAND MAL CONVULSION | 4 0.04 33.19 GROIN INFECTION | 1 0.01 33.20 GROWTH HORMONE DEFICIENCY | 3 0.03 33.23 H1N1 INFLUENZA | 1 0.01 33.24 HAEMANGIOMA | 3 0.03 33.27 HAEMATOMA | 1 0.01 33.28 HAEMATOPOIETIC STEM CELL MOBILISATION | 2 0.02 33.30 HAEMOLYTIC URAEMIC SYNDROME | 2 0.02 33.32 HAEMOPHILIA | 5 0.05 33.37 HAEMORRHAGE | 2 0.02 33.39 HAEMORRHOIDS | 4 0.04 33.43 HALLUCINATION | 2 0.02 33.45 HEAD AND NECK CANCER | 20 0.20 33.65 HEADACHE | 28 0.28 33.93 HEART DISEASE CONGENITAL | 1 0.01 33.94 HEART RATE INCREASED | 1 0.01 33.95 HEART RATE IRREGULAR | 5 0.05 34.00 HEART TRANSPLANT | 3 0.03 34.03 HELICOBACTER INFECTION | 1 0.01 34.04 HENOCH-SCHONLEIN PURPURA | 2 0.02 34.06 HEPATIC CANCER METASTATIC | 1 0.01 34.07 HEPATIC CIRRHOSIS | 2 0.02 34.09 HEPATIC FUNCTION ABNORMAL | 1 0.01 34.10 HEPATIC NEOPLASM MALIGNANT | 20 0.20 34.30 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 2 0.02 34.32 HEPATITIS B | 4 0.04 34.36 HEPATITIS B CORE ANTIGEN POSITIVE | 1 0.01 34.37 HEPATITIS B E ANTIGEN POSITIVE | 1 0.01 34.38 HEPATITIS B SURFACE ANTIGEN POSITIVE | 1 0.01 34.39 HEPATITIS C | 31 0.31 34.70 HERNIA | 3 0.03 34.73 HERPES VIRUS INFECTION | 2 0.02 34.75 HERPES ZOSTER | 9 0.09 34.84 HIATUS HERNIA | 1 0.01 34.85 HICCUPS | 6 0.06 34.91 HIGH DENSITY LIPOPROTEIN | 1 0.01 34.92 HIGH DENSITY LIPOPROTEIN DECREASED | 4 0.04 34.96 HIRSUTISM | 2 0.02 34.98 HIV INFECTION | 93 0.93 35.91 HODGKIN'S DISEASE | 11 0.11 36.02 HORMONE LEVEL ABNORMAL | 2 0.02 36.04 HORMONE REPLACEMENT THERAPY | 20 0.20 36.24 HORMONE SUPPRESSION THERAPY | 1 0.01 36.25 HORMONE THERAPY | 4 0.04 36.29 HOT FLUSH | 7 0.07 36.36 HYPERAMMONAEMIA | 1 0.01 36.37 HYPERCHOLESTEROLAEMIA | 29 0.29 36.66 HYPERGLYCAEMIA | 3 0.03 36.69 HYPERKERATOSIS PALMARIS AND PLANTARIS | 1 0.01 36.70 HYPERLIPIDAEMIA | 13 0.13 36.83 HYPERPARATHYROIDISM SECONDARY | 4 0.04 36.87 HYPERPHOSPHATAEMIA | 4 0.04 36.91 HYPERSENSITIVITY | 24 0.24 37.15 HYPERTENSION | 411 4.11 41.26 HYPERTHYROIDISM | 1 0.01 41.27 HYPERTONIC BLADDER | 3 0.03 41.30 HYPERTRICHOSIS | 1 0.01 41.31 HYPERTRIGLYCERIDAEMIA | 2 0.02 41.33 HYPERURICAEMIA | 10 0.10 41.43 HYPOAESTHESIA | 1 0.01 41.44 HYPOALBUMINAEMIA | 1 0.01 41.45 HYPOCALCAEMIA | 1 0.01 41.46 HYPOGAMMAGLOBULINAEMIA | 1 0.01 41.47 HYPOKALAEMIA | 4 0.04 41.51 HYPOPARATHYROIDISM | 1 0.01 41.52 HYPOPITUITARISM | 2 0.02 41.54 HYPOTHYROIDISM | 38 0.38 41.92 HYPOVITAMINOSIS | 1 0.01 41.93 HYPOXIA | 1 0.01 41.94 HYSTERECTOMY | 2 0.02 41.96 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 52 0.52 42.48 ILL-DEFINED DISORDER | 10 0.10 42.58 IMAGING PROCEDURE | 4 0.04 42.62 IMMUNISATION | 2 0.02 42.64 IMMUNODEFICIENCY | 2 0.02 42.66 IMMUNOSUPPRESSANT DRUG THERAPY | 1 0.01 42.67 IMMUNOSUPPRESSION | 21 0.21 42.88 INDUCTION OF ANAESTHESIA | 4 0.04 42.92 INFARCTION | 1 0.01 42.93 INFECTION | 13 0.13 43.06 INFECTION PROPHYLAXIS | 26 0.26 43.32 INFECTIOUS PERITONITIS | 2 0.02 43.34 INFLAMMATION | 12 0.12 43.46 INFLAMMATORY BOWEL DISEASE | 4 0.04 43.50 INFLUENZA | 10 0.10 43.60 INSOMNIA | 39 0.39 43.99 INSULIN RESISTANCE | 1 0.01 44.00 INTENTIONAL OVERDOSE | 4 0.04 44.04 INTENTIONAL SELF-INJURY | 2 0.02 44.06 INTERSTITIAL LUNG DISEASE | 7 0.07 44.13 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 44.15 INTESTINAL ISCHAEMIA | 1 0.01 44.16 INTESTINAL OBSTRUCTION | 1 0.01 44.17 INTESTINAL RESECTION | 1 0.01 44.18 INTESTINE TRANSPLANT REJECTION | 1 0.01 44.19 INTRA-THORACIC AORTIC ANEURYSM REPAIR | 1 0.01 44.20 INTRAOCULAR PRESSURE INCREASED | 1 0.01 44.21 INTRAOCULAR PRESSURE TEST ABNORMAL | 2 0.02 44.23 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 44.24 IRON DEFICIENCY | 4 0.04 44.28 IRON DEFICIENCY ANAEMIA | 1 0.01 44.29 IRON OVERLOAD | 15 0.15 44.44 IRRITABLE BOWEL SYNDROME | 8 0.08 44.52 ISCHAEMIC CARDIOMYOPATHY | 3 0.03 44.55 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 4 0.04 44.59 ISOLATED ADRENOCORTICOTROPIC HORMONE .. | 4 0.04 44.63 JOINT SWELLING | 1 0.01 44.64 JUVENILE ARTHRITIS | 18 0.18 44.82 KERATITIS | 1 0.01 44.83 KLINEFELTER'S SYNDROME | 2 0.02 44.85 KNEE ARTHROPLASTY | 1 0.01 44.86 LABYRINTHITIS | 1 0.01 44.87 LATENT TUBERCULOSIS | 1 0.01 44.88 LENNOX-GASTAUT SYNDROME | 1 0.01 44.89 LEUKAEMIA | 3 0.03 44.92 LEUKOCYTOSIS | 1 0.01 44.93 LEUKOPENIA | 2 0.02 44.95 LICHEN SCLEROSUS | 1 0.01 44.96 LIPIDS ABNORMAL | 4 0.04 45.00 LIPODYSTROPHY ACQUIRED | 1 0.01 45.01 LIVER DISORDER | 1 0.01 45.02 LIVER TRANSPLANT | 1 0.01 45.03 LOCAL ANAESTHESIA | 2 0.02 45.05 LOW DENSITY LIPOPROTEIN INCREASED | 4 0.04 45.09 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 45.11 LUMBAR SPINAL STENOSIS | 1 0.01 45.12 LUNG ADENOCARCINOMA | 8 0.08 45.20 LUNG ADENOCARCINOMA RECURRENT | 1 0.01 45.21 LUNG ADENOCARCINOMA STAGE III | 1 0.01 45.22 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 10 0.10 45.32 LUNG DISORDER | 2 0.02 45.34 LUNG NEOPLASM MALIGNANT | 20 0.20 45.54 LUNG TRANSPLANT | 9 0.09 45.63 LYMPHOCYTIC LEUKAEMIA | 4 0.04 45.67 LYMPHOEDEMA | 2 0.02 45.69 LYMPHOMA | 7 0.07 45.76 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 45.77 MACULAR DEGENERATION | 1 0.01 45.78 MACULAR OEDEMA | 1 0.01 45.79 MAJOR DEPRESSION | 8 0.08 45.87 MALARIA PROPHYLAXIS | 2 0.02 45.89 MALIGNANT MELANOMA | 6 0.06 45.95 MALIGNANT NEOPLASM OF PLACENTA | 1 0.01 45.96 MALIGNANT NEOPLASM OF RENAL PELVIS | 1 0.01 45.97 MALIGNANT SOFT TISSUE NEOPLASM | 1 0.01 45.98 MANIA | 6 0.06 46.04 MANTLE CELL LYMPHOMA | 6 0.06 46.10 MATERNAL EXPOSURE DURING PREGNANCY | 27 0.27 46.37 MEDICAL DIET | 8 0.08 46.45 MEMORY IMPAIRMENT | 1 0.01 46.46 MENIERE'S DISEASE | 1 0.01 46.47 MENOMETRORRHAGIA | 1 0.01 46.48 MENOPAUSAL SYMPTOMS | 5 0.05 46.53 MENOPAUSE | 2 0.02 46.55 MENORRHAGIA | 23 0.23 46.78 MENSTRUAL CYCLE MANAGEMENT | 14 0.14 46.92 MENSTRUAL DISCOMFORT | 1 0.01 46.93 MENSTRUAL DISORDER | 7 0.07 47.00 MENSTRUATION IRREGULAR | 22 0.22 47.22 MENTAL DISORDER | 1 0.01 47.23 METASTASES TO BONE | 18 0.18 47.41 METASTASES TO BONE MARROW | 1 0.01 47.42 METASTASES TO CENTRAL NERVOUS SYSTEM | 3 0.03 47.45 METASTASES TO LUNG | 2 0.02 47.47 METASTASIS | 1 0.01 47.48 METASTATIC CARCINOID TUMOUR | 1 0.01 47.49 METASTATIC MALIGNANT MELANOMA | 36 0.36 47.85 METASTATIC RENAL CELL CARCINOMA | 40 0.40 48.25 METRORRHAGIA | 2 0.02 48.27 MIGRAINE | 31 0.31 48.58 MIGRAINE PROPHYLAXIS | 3 0.03 48.61 MINERAL SUPPLEMENTATION | 8 0.08 48.69 MITRAL VALVE DISEASE | 1 0.01 48.70 MITRAL VALVE REPAIR | 2 0.02 48.72 MITRAL VALVE REPLACEMENT | 10 0.10 48.82 MUCOPOLYSACCHARIDOSIS II | 2 0.02 48.84 MUCOSAL ULCERATION | 2 0.02 48.86 MULTIPLE ALLERGIES | 17 0.17 49.03 MULTIPLE INJURIES | 1 0.01 49.04 MULTIPLE MYELOMA | 80 0.80 49.84 MULTIPLE SCLEROSIS | 476 4.76 54.60 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 54.62 MUSCLE DISORDER | 1 0.01 54.63 MUSCLE RELAXANT THERAPY | 9 0.09 54.72 MUSCLE RUPTURE | 1 0.01 54.73 MUSCLE SPASMS | 12 0.12 54.85 MUSCLE SPASTICITY | 4 0.04 54.89 MUSCLE TIGHTNESS | 4 0.04 54.93 MUSCULOSKELETAL CHEST PAIN | 2 0.02 54.95 MUSCULOSKELETAL DISCOMFORT | 1 0.01 54.96 MUSCULOSKELETAL DISORDER | 1 0.01 54.97 MUSCULOSKELETAL PAIN | 5 0.05 55.02 MYALGIA | 4 0.04 55.06 MYASTHENIA GRAVIS | 2 0.02 55.08 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 2 0.02 55.10 MYELODYSPLASTIC SYNDROME | 17 0.17 55.27 MYOCARDIAL INFARCTION | 3 0.03 55.30 MYOCARDIAL ISCHAEMIA | 5 0.05 55.35 MYOCLONIC EPILEPSY | 3 0.03 55.38 MYXOEDEMA | 1 0.01 55.39 NARCOLEPSY | 1 0.01 55.40 NASAL CONGESTION | 1 0.01 55.41 NASOPHARYNGITIS | 4 0.04 55.45 NAUSEA | 51 0.51 55.96 NECK PAIN | 3 0.03 55.99 NECROTISING RETINITIS | 1 0.01 56.00 NEOPLASM | 5 0.05 56.05 NEOPLASM MALIGNANT | 3 0.03 56.08 NEPHROGENIC ANAEMIA | 1 0.01 56.09 NEPHROPATHY | 1 0.01 56.10 NEPHROTIC SYNDROME | 6 0.06 56.16 NERVE INJURY | 1 0.01 56.17 NERVOUS SYSTEM DISORDER | 1 0.01 56.18 NEURALGIA | 11 0.11 56.29 NEUROENDOCRINE CARCINOMA | 3 0.03 56.32 NEUROENDOCRINE TUMOUR | 3 0.03 56.35 NEUROPATHY PERIPHERAL | 9 0.09 56.44 NEUTROPENIA | 1 0.01 56.45 NON-HODGKIN'S LYMPHOMA | 18 0.18 56.63 NON-HODGKIN'S LYMPHOMA UNSPECIFIED HI.. | 9 0.09 56.72 NON-SMALL CELL LUNG CANCER | 37 0.37 57.09 NON-SMALL CELL LUNG CANCER METASTATIC | 1 0.01 57.10 NON-SMALL CELL LUNG CANCER STAGE IV | 5 0.05 57.15 NUCLEAR MAGNETIC RESONANCE IMAGING | 62 0.62 57.77 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 15 0.15 57.92 NUTRITIONAL SUPPORT | 1 0.01 57.93 OBESITY | 1 0.01 57.94 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 57.96 OEDEMA | 7 0.07 58.03 OEDEMA MOUTH | 2 0.02 58.05 OEDEMA PERIPHERAL | 5 0.05 58.10 OESOPHAGEAL ADENOCARCINOMA | 2 0.02 58.12 OESOPHAGEAL CARCINOMA | 10 0.10 58.22 OESOPHAGEAL IRRITATION | 2 0.02 58.24 OFF LABEL USE | 2 0.02 58.26 ONYCHOMYCOSIS | 4 0.04 58.30 OPPORTUNISTIC INFECTION PROPHYLAXIS | 1 0.01 58.31 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 58.32 OPTIC NEURITIS | 1 0.01 58.33 ORAL CONTRACEPTION | 42 0.42 58.75 ORCHITIS | 1 0.01 58.76 OROPHARYNGEAL PAIN | 1 0.01 58.77 ORTHOSTATIC HYPOTENSION | 1 0.01 58.78 OSTEITIS | 2 0.02 58.80 OSTEITIS DEFORMANS | 1 0.01 58.81 OSTEOARTHRITIS | 11 0.11 58.92 OSTEOCHONDROSIS | 3 0.03 58.95 OSTEOMYELITIS | 1 0.01 58.96 OSTEOMYELITIS CHRONIC | 6 0.06 59.02 OSTEOPENIA | 34 0.34 59.36 OSTEOPOROSIS | 164 1.64 61.00 OSTEOPOROSIS POSTMENOPAUSAL | 24 0.24 61.24 OSTEOPOROSIS PROPHYLAXIS | 14 0.14 61.38 OSTEOPOROTIC FRACTURE | 1 0.01 61.39 OTITIS MEDIA | 1 0.01 61.40 OVARIAN CANCER | 2 0.02 61.42 OVARIAN CANCER METASTATIC | 3 0.03 61.45 OVARIAN CANCER RECURRENT | 9 0.09 61.54 OVARIAN CYST | 5 0.05 61.59 OVARIAN EPITHELIAL CANCER | 3 0.03 61.62 OVARIAN NEOPLASM | 1 0.01 61.63 OVULATION INDUCTION | 8 0.08 61.71 OXYGEN SUPPLEMENTATION | 1 0.01 61.72 PAIN | 153 1.53 63.25 PAIN IN EXTREMITY | 10 0.10 63.35 PAIN MANAGEMENT | 13 0.13 63.48 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 4 0.04 63.52 PALPITATIONS | 1 0.01 63.53 PANCREATIC CARCINOMA | 6 0.06 63.59 PANCREATIC CARCINOMA METASTATIC | 3 0.03 63.62 PANCREATIC CARCINOMA RECURRENT | 3 0.03 63.65 PANCREATIC DISORDER | 1 0.01 63.66 PANCREATIC INSUFFICIENCY | 1 0.01 63.67 PANIC ATTACK | 1 0.01 63.68 PANIC DISORDER | 5 0.05 63.73 PARAESTHESIA | 1 0.01 63.74 PARKINSON'S DISEASE | 33 0.33 64.07 PARKINSONISM | 1 0.01 64.08 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 3 0.03 64.11 PELVIC PAIN | 2 0.02 64.13 PERCUTANEOUS CORONARY INTERVENTION | 2 0.02 64.15 PERIARTHRITIS | 2 0.02 64.17 PERICARDITIS | 5 0.05 64.22 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 64.23 PERIPHERAL VASCULAR DISORDER | 1 0.01 64.24 PERITONEAL DIALYSIS | 75 0.75 64.99 PERITONSILLITIS | 1 0.01 65.00 PERSONALITY DISORDER | 3 0.03 65.03 PETIT MAL EPILEPSY | 2 0.02 65.05 PHARYNGITIS | 2 0.02 65.07 PITUITARY TUMOUR | 1 0.01 65.08 PITYRIASIS RUBRA PILARIS | 2 0.02 65.10 PLATELET AGGREGATION INHIBITION | 1 0.01 65.11 PLEURAL EFFUSION | 6 0.06 65.17 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 65.19 PNEUMONIA | 12 0.12 65.31 POLLAKIURIA | 1 0.01 65.32 POLYARTHRITIS | 6 0.06 65.38 POLYCYSTIC OVARIES | 4 0.04 65.42 POLYCYTHAEMIA VERA | 3 0.03 65.45 POST COITAL CONTRACEPTION | 64 0.64 66.09 POST HERPETIC NEURALGIA | 3 0.03 66.12 POST PROCEDURAL INFECTION | 1 0.01 66.13 POST-THORACOTOMY PAIN SYNDROME | 6 0.06 66.19 POST-TRAUMATIC HEADACHE | 1 0.01 66.20 POST-TRAUMATIC NECK SYNDROME | 1 0.01 66.21 POST-TRAUMATIC STRESS DISORDER | 4 0.04 66.25 POSTOPERATIVE CARE | 2 0.02 66.27 POSTOPERATIVE FEVER | 1 0.01 66.28 POSTPARTUM DEPRESSION | 1 0.01 66.29 PRE-EXISTING DISEASE | 1 0.01 66.30 PRECOCIOUS PUBERTY | 1 0.01 66.31 PREMEDICATION | 52 0.52 66.83 PREMENSTRUAL SYNDROME | 94 0.94 67.77 PREOPERATIVE CARE | 7 0.07 67.84 PRIMARY HYPOTHYROIDISM | 1 0.01 67.85 PRINZMETAL ANGINA | 1 0.01 67.86 PROCEDURAL PAIN | 3 0.03 67.89 PRODUCT USED FOR UNKNOWN INDICATION | 1,499 14.99 82.88 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 82.89 PROMOTION OF PERIPHERAL CIRCULATION | 1 0.01 82.90 PROPHYLAXIS | 190 1.90 84.80 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 6 0.06 84.86 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 19 0.19 85.05 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 6 0.06 85.11 PROPHYLAXIS OF NAUSEA AND VOMITING | 16 0.16 85.27 PROPHYLAXIS OF NEURAL TUBE DEFECT | 3 0.03 85.30 PROSTATE CANCER | 38 0.38 85.68 PROSTATE CANCER METASTATIC | 13 0.13 85.81 PROSTATIC ADENOMA | 1 0.01 85.82 PROSTATIC DISORDER | 3 0.03 85.85 PROSTATIC OPERATION | 1 0.01 85.86 PROSTATIC SPECIFIC ANTIGEN | 1 0.01 85.87 PROSTATOMEGALY | 3 0.03 85.90 PRURIGO | 2 0.02 85.92 PRURITUS | 4 0.04 85.96 PSEUDOMONAS INFECTION | 4 0.04 86.00 PSORIASIS | 45 0.45 86.45 PSORIATIC ARTHROPATHY | 26 0.26 86.71 PSYCHIATRIC SYMPTOM | 6 0.06 86.77 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 86.78 PSYCHOTIC DISORDER | 24 0.24 87.02 PULMONARY ARTERIAL HYPERTENSION | 46 0.46 87.48 PULMONARY ARTERY THERAPEUTIC PROCEDURE | 1 0.01 87.49 PULMONARY EMBOLISM | 8 0.08 87.57 PULMONARY HYPERTENSION | 30 0.30 87.87 PULMONARY INFARCTION | 2 0.02 87.89 PULMONARY OEDEMA | 1 0.01 87.90 PUSTULAR PSORIASIS | 4 0.04 87.94 PYREXIA | 17 0.17 88.11 RADICULAR PAIN | 1 0.01 88.12 RADIOTHERAPY | 1 0.01 88.13 RASH | 3 0.03 88.16 RAYNAUD'S PHENOMENON | 4 0.04 88.20 RECTAL CANCER | 7 0.07 88.27 RECTAL CANCER METASTATIC | 2 0.02 88.29 RECTAL CANCER RECURRENT | 2 0.02 88.31 RECTOSIGMOID CANCER | 1 0.01 88.32 RELAPSING FEVER | 1 0.01 88.33 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 21 0.21 88.54 RENAL AND PANCREAS TRANSPLANT | 1 0.01 88.55 RENAL CANCER | 10 0.10 88.65 RENAL CANCER METASTATIC | 2 0.02 88.67 RENAL CELL CARCINOMA | 27 0.27 88.94 RENAL DISORDER | 2 0.02 88.96 RENAL FAILURE | 2 0.02 88.98 RENAL FAILURE ACUTE | 2 0.02 89.00 RENAL FAILURE CHRONIC | 14 0.14 89.14 RENAL IMPAIRMENT | 1 0.01 89.15 RENAL TRANSPLANT | 53 0.53 89.68 RENAL VESSEL DISORDER | 1 0.01 89.69 RESPIRATORY DISORDER | 1 0.01 89.70 RESPIRATORY TRACT CONGESTION | 1 0.01 89.71 RESPIRATORY TRACT INFECTION | 4 0.04 89.75 RESTLESS LEGS SYNDROME | 6 0.06 89.81 RESTLESSNESS | 2 0.02 89.83 RESTRICTIVE PULMONARY DISEASE | 2 0.02 89.85 REVISION OF INTERNAL FIXATION | 2 0.02 89.87 RHEUMATOID ARTHRITIS | 242 2.42 92.29 RHEUMATOID VASCULITIS | 4 0.04 92.33 RHINITIS | 4 0.04 92.37 RHINITIS ALLERGIC | 5 0.05 92.42 ROSACEA | 2 0.02 92.44 ROUTINE HEALTH MAINTENANCE | 6 0.06 92.50 SALIVARY HYPERSECRETION | 3 0.03 92.53 SARCOIDOSIS | 1 0.01 92.54 SARCOMA | 1 0.01 92.55 SARCOMA METASTATIC | 5 0.05 92.60 SARCOMA UTERUS | 2 0.02 92.62 SCAN | 1 0.01 92.63 SCAN BRAIN | 1 0.01 92.64 SCAN MYOCARDIAL PERFUSION | 1 0.01 92.65 SCAN WITH CONTRAST | 2 0.02 92.67 SCHIZOAFFECTIVE DISORDER | 6 0.06 92.73 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE | 1 0.01 92.74 SCHIZOPHRENIA | 95 0.95 93.69 SCHIZOPHRENIA, PARANOID TYPE | 2 0.02 93.71 SCHNITZLER'S SYNDROME | 1 0.01 93.72 SCIATICA | 1 0.01 93.73 SCLERODERMA | 4 0.04 93.77 SEASONAL ALLERGY | 5 0.05 93.82 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 93.83 SEDATION | 3 0.03 93.86 SEDATIVE THERAPY | 1 0.01 93.87 SENILE OSTEOPOROSIS | 2 0.02 93.89 SEPSIS | 2 0.02 93.91 SEPTIC ARTHRITIS STAPHYLOCOCCAL | 1 0.01 93.92 SERONEGATIVE ARTHRITIS | 2 0.02 93.94 SICKLE CELL ANAEMIA | 28 0.28 94.22 SIGMOIDITIS | 1 0.01 94.23 SIGMOIDOSCOPY | 1 0.01 94.24 SINUS DISORDER | 2 0.02 94.26 SINUS HEADACHE | 2 0.02 94.28 SINUSITIS | 5 0.05 94.33 SKIN DISORDER | 1 0.01 94.34 SKIN FISSURES | 1 0.01 94.35 SKIN LESION | 2 0.02 94.37 SKIN PAPILLOMA | 2 0.02 94.39 SKIN TEST | 1 0.01 94.40 SKIN ULCER | 1 0.01 94.41 SLEEP APNOEA SYNDROME | 2 0.02 94.43 SLEEP DISORDER | 22 0.22 94.65 SLEEP DISORDER THERAPY | 5 0.05 94.70 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 5 0.05 94.75 SMOKING CESSATION THERAPY | 47 0.47 95.22 SOMNOLENCE | 1 0.01 95.23 SPINAL ANAESTHESIA | 2 0.02 95.25 SPINAL COLUMN STENOSIS | 2 0.02 95.27 SPINAL COMPRESSION FRACTURE | 1 0.01 95.28 SPINAL OPERATION | 4 0.04 95.32 SPONDYLOARTHROPATHY | 1 0.01 95.33 STAPHYLOCOCCAL INFECTION | 2 0.02 95.35 STAPHYLOCOCCAL SEPSIS | 2 0.02 95.37 STEM CELL TRANSPLANT | 30 0.30 95.67 STENT PLACEMENT | 6 0.06 95.73 STEROID THERAPY | 1 0.01 95.74 STREPTOCOCCAL INFECTION | 1 0.01 95.75 STRESS | 2 0.02 95.77 STRESS URINARY INCONTINENCE | 2 0.02 95.79 STRONGYLOIDIASIS | 1 0.01 95.80 SUBCUTANEOUS ABSCESS | 1 0.01 95.81 SUICIDE ATTEMPT | 9 0.09 95.90 SUPPLEMENTATION THERAPY | 13 0.13 96.03 SUPRAVENTRICULAR TACHYCARDIA | 4 0.04 96.07 SURGERY | 3 0.03 96.10 SWELLING | 3 0.03 96.13 SYMPHYSIOLYSIS | 8 0.08 96.21 SYNCOPE | 1 0.01 96.22 SYSTEMIC CANDIDA | 1 0.01 96.23 SYSTEMIC LUPUS ERYTHEMATOSUS | 10 0.10 96.33 SYSTEMIC SCLEROSIS | 2 0.02 96.35 T-CELL LYMPHOMA | 6 0.06 96.41 T-CELL LYMPHOMA STAGE IV | 1 0.01 96.42 T-CELL PROLYMPHOCYTIC LEUKAEMIA | 1 0.01 96.43 T-CELL TYPE ACUTE LEUKAEMIA | 4 0.04 96.47 TACHYCARDIA | 5 0.05 96.52 TEMPORAL ARTERITIS | 1 0.01 96.53 TENOSYNOVITIS | 1 0.01 96.54 TESTICULAR PAIN | 1 0.01 96.55 THALASSAEMIA | 1 0.01 96.56 THALASSAEMIA BETA | 1 0.01 96.57 THROMBOCYTOPENIA | 2 0.02 96.59 THROMBOLYSIS | 1 0.01 96.60 THROMBOPHLEBITIS | 3 0.03 96.63 THROMBOSIS IN DEVICE | 1 0.01 96.64 THROMBOSIS PROPHYLAXIS | 30 0.30 96.94 THYROID CANCER | 5 0.05 96.99 THYROID DISORDER | 17 0.17 97.16 THYROID FUNCTION TEST ABNORMAL | 2 0.02 97.18 THYROID HORMONE REPLACEMENT THERAPY | 1 0.01 97.19 THYROIDECTOMY | 1 0.01 97.20 TINEA PEDIS | 1 0.01 97.21 TOBACCO ABUSE | 1 0.01 97.22 TOBACCO USER | 1 0.01 97.23 TOOTH ABSCESS | 1 0.01 97.24 TOOTH DISORDER | 1 0.01 97.25 TOOTHACHE | 1 0.01 97.26 TORTICOLLIS | 2 0.02 97.28 TOURETTE'S DISORDER | 1 0.01 97.29 TOXICITY TO VARIOUS AGENTS | 1 0.01 97.30 TOXOCARIASIS | 1 0.01 97.31 TRANSITIONAL CELL CARCINOMA | 3 0.03 97.34 TRICUSPID VALVE REPAIR | 2 0.02 97.36 TRICUSPID VALVE REPLACEMENT | 1 0.01 97.37 TUBERCULIN TEST | 2 0.02 97.39 TUBERCULOSIS | 5 0.05 97.44 TUBEROUS SCLEROSIS | 4 0.04 97.48 TUBULOINTERSTITIAL NEPHRITIS | 2 0.02 97.50 TURNER'S SYNDROME | 1 0.01 97.51 TYPE 1 DIABETES MELLITUS | 6 0.06 97.57 TYPE 2 DIABETES MELLITUS | 107 1.07 98.64 TYPE IIA HYPERLIPIDAEMIA | 1 0.01 98.65 ULCER | 2 0.02 98.67 UNEVALUABLE EVENT | 8 0.08 98.75 UPPER RESPIRATORY TRACT INFECTION | 6 0.06 98.81 URETERIC CANCER | 1 0.01 98.82 URETHRITIS | 1 0.01 98.83 URINARY INCONTINENCE | 5 0.05 98.88 URINARY RETENTION | 1 0.01 98.89 URINARY TRACT DISORDER | 1 0.01 98.90 URINARY TRACT INFECTION | 19 0.19 99.09 UROSEPSIS | 3 0.03 99.12 URTICARIA | 4 0.04 99.16 URTICARIA CHRONIC | 2 0.02 99.18 UTERINE DISORDER | 1 0.01 99.19 UTERINE LEIOMYOMA | 1 0.01 99.20 VAGINAL HAEMORRHAGE | 1 0.01 99.21 VAGINAL INFECTION | 1 0.01 99.22 VASCULAR GRAFT | 1 0.01 99.23 VASODILATATION | 1 0.01 99.24 VENOGRAM | 7 0.07 99.31 VENOGRAM RENAL | 2 0.02 99.33 VENOUS INSUFFICIENCY | 3 0.03 99.36 VENTRICULAR ARRHYTHMIA | 2 0.02 99.38 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.39 VENTRICULAR SEPTAL DEFECT REPAIR | 1 0.01 99.40 VERTIGO | 2 0.02 99.42 VIPOMA | 2 0.02 99.44 VISION BLURRED | 1 0.01 99.45 VITAMIN B12 | 1 0.01 99.46 VITAMIN B12 DECREASED | 1 0.01 99.47 VITAMIN B12 DEFICIENCY | 2 0.02 99.49 VITAMIN D DEFICIENCY | 6 0.06 99.55 VITAMIN SUPPLEMENTATION | 10 0.10 99.65 VOMITING | 9 0.09 99.74 VULVOVAGINAL BURNING SENSATION | 1 0.01 99.75 VULVOVAGINAL DISCOMFORT | 1 0.01 99.76 VULVOVAGINAL DRYNESS | 5 0.05 99.81 VULVOVAGINAL PRURITUS | 2 0.02 99.83 VULVOVAGINITIS | 1 0.01 99.84 WEIGHT CONTROL | 1 0.01 99.85 WEIGHT DECREASED | 3 0.03 99.88 WHEEZING | 1 0.01 99.89 WHITE BLOOD CELL COUNT INCREASED | 2 0.02 99.91 WHOLE BODY SCAN | 1 0.01 99.92 WOLFF-PARKINSON-WHITE SYNDROME | 2 0.02 99.94 WOUND HAEMORRHAGE | 1 0.01 99.95 WOUND INFECTION | 2 0.02 99.97 ZINC DEFICIENCY | 3 0.03 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015